🔴 Recursion Pharmaceuticals is trading 5.52% down today as U.S. equities retreat

Recursion Pharmaceuticals is trading 5.52% down at $3.25 as broad risk-off pressure weighs on U.S. equities.

• The S&P 500 is down 0.45%, while the Nasdaq Composite is down 0.61%.
• No clear company-specific announcement explains the September 9, 2026 decline.
• Recent coverage references earlier quarterly results, cash-burn concerns, and insider selling rather than a new catalyst.